Brand Strength·Industry Endorsement
Industry Endorsement
Nationally recognised. Trusted by the industry.
🏛️ National-Level Endorsement
112 Projects
Nationally Approved StemCell Registry
Doublle Bio operates within the framework of China’s national stem cell registry-the highest regulatory standard.
23 Projects
Stem Cell New Drug Clinical Approvals
Multiple investigational new drug approvals granted demonstrating R&D strength and regulatory compliance.
Full Oversight
National Health & Drug Authority Supervision
All R&D, manufacturing and clinical operations are supervised by national health and pharmaceutical regulators
🤝 Industry Recognition
●
A Key Player in China’s Stem Cell Sector
Doublle Bio is one of China’s leading stem cellenterprises, actively participating in industry collaboration with research institutes and medical institutions to advance stem cell science and application.
●
Strong Industry Reputation & Patient Trust
Through expert teams, robust technology and premium service, Doublle Bio has buit an outstanding industry reputation and earned the trust of a growing base of satisfied patients
●
Driving Industry Standardisation
Committed to standardised, compliant operations, Doublle Bio’s mature systems across R&D, manufacturing and clinical services provide a meaningful benchmark for the broaderindustry.